Shanghai Henlius Biotech, Inc. announced that its first self-developed innovative PD-1 inhibitor HANSIZHUANG has been approved by the National Medical Products Administration (NMPA) for...
NeuroSense Therapeutics Ltd. ("NeuroSense"), a company developing treatments for severe neurodegenerative diseases, announced it has received proceeds of approximately $4 million from the exercise...
Advanced Oxygen Therapy Inc. (AOTI), the global leader in noninvasive topical oxygen wound healing solutions, announced they have closed a significant round of growth...
Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced that NVX-CoV2373, its protein-based COVID-19 vaccine, is...
Novartis announced today that the US Food and Drug Administration (FDA) approved Pluvicto™ (lutetium Lu 177 vipivotide tetraxetan) (formerly referred to as 177Lu-PSMA-617) for...
